Tg Therapeutics reported $-69013000 in Net Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 4490M 446M
Amgen AMGN:US $ 1476M 423M
Ardelyx ARDX:US $ -28.07M 8.16M
Arrowhead Research ARWR:US $ 44.37M 107.24M
Bayer BAYN:GR € 3291M 2130M
Biogen BIIB:US $ 303.8M 64.4M
Corcept Therapeutics CORT:US $ 22.8M 9.26M
Curis CRIS:US $ -16.11M 2.49M
Dynavax Technologies DVAX:US $ 32.86M 66.92M
Gilead Sciences GILD:US $ 19M 363M
Infinity Pharmaceuticals INFI:US $ -12.44M 0.78M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
Johnson & Johnson JNJ:US $ 5149M 413M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Novartis NOVN:VX SF 2222M 14086M
Novavax NVAX:US $ 203.41M 1049.69M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Puma Biotechnology PBYI:US $ -3.4M 7.63M
Regeneron Pharmaceuticals REGN:US $ 973.5M 1255.5M
Spectrum Pharmaceuticals SPPI:US $ -15.44M 24.27M
Tg Therapeutics TGTX:US $ -69.01M 24.32M
Verastem VSTM:US $ -16.96M 0.48M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Ziopharm Oncology ZIOP:US $ -9.79M 2.01M